ArticleEuropean heart journal. Cardiovascular Imaging2026
Smoking cessation after first STEMI enhances infarct healing: a cardiac MRI study.
Article in European heart journal. Cardiovascular Imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Commented on by
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimsSmoking cessation represents an important step in primary and secondary prevention of myocardial infarction. While there are few data on the extent of initial myocardial damage in current smokers, there are hardly any data on the evolution of the infarct in active smokers and in patients giving up smoking. This prospective study investigated infarct dynamics in patients quitting smoking after ST-elevation myocardial infarction (STEMI). METHODS AND
resultsOverall, 672 revascularized first-time STEMI patients were included. Smoking behaviour was documented at baseline and after 4 months. Cardiac magnetic resonance imaging (CMR) was performed at baseline and after 4 and 12 months, including infarct characteristics evaluation. Major adverse cardiac events (MACE) comprised all-cause death and reinfarction within a median observation period of 3.4 years. Initially, 382 patients (57%) were active smokers, of whom 183 (48%) quit smoking after the infarction. There were no differences in initial infarct size; however, at follow-up CMR examinations, infarct size reduced more in the cessation group compared to continuing smokers (after 12 months: 62% vs. 47%, P < 0.001). Additionally, MACE occurred less often in quitters (4%vs. 12%, P = 0.005). In multivariable logistic regression, continuing smoking was predictive of reduced infarct healing; in multivariable Cox-regression, it was a marker for MACE, independent of traditional cardiovascular risk markers.
conclusionSmoking cessation after the first STEMI appears to be an important factor positively influencing infarct healing. Within the observation period, fewer patients died in the cessation group. In sum, these data provide another valuable argument for quitting smoking, even after an infarction had already occurred.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.